Incitec Pivot Limited (ASX: IPL) reported a AU$582 million Net Profit After Tax (NPAT), excluding significant items, its second-highest since 2008. However, FY23 Earnings Before Interest and Tax (EBIT) excluding IMIs decreased to AU$880 million from the record FY22 performance of AU$1,485 million, influenced by a less favourable commodity price environment. The company disclosed its intention to return up to AU$1.4 billion to shareholders contingent on the successful completion of the Waggaman ammonia facility sale.
Notably, the Total Recordable Injury Frequency Rate (TRIFR) improved to 0.91. Statutory NPAT was AU$560 million, and EBIT ex IMIs, adjusted for commodity and forex impacts, increased by 10% compared to the prior year. Earnings Per Share ex IMIs stood at 30.0 cents, down from 52.9 cps in FY22, while Return on Invested Capital (ROIC) including goodwill was 7.5% (FY22: 13.8%). A final dividend of 5 cents per share (unfranked) was declared, resulting in a total FY23 dividend of 15 cents per share, representing a 50% payout ratio. Plans include returning up to AU$1.0 billion from the Waggaman sale to shareholders, in addition to the previously announced up to AU$400 million on-market buyback.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 20, 2024
Nov 20, 2024
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.